Biotech Values

[DewDiligence]

MNTA—I've seen a couple of 10b5-1 Plans where all the participants went with the same algorithm.

You’re hypothesizing that MNTA’s eight insiders* with 10b5-1 plans not only employ the same trading algorithm, but also that the algorithm happens to specify a significantly higher price threshold for a sale beginning on or about 9/1/12—a date with no particular relevance to MNTA’s compensation plans or business development. Possible, I suppose, but not likely.

p.s. Today marks 30 days without a 10b5-1 sale.

*Six officers and two directors.